REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nefrocontrol S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nefrocontrol S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Nefrocontrol S.A. is based in Ecuador. The head office is in Quito. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 07, 1998. It currently has a total number of 162 (2023) employees. In 2023, the company reported a net sales revenue increase of 15.59%. During that time, Nefrocontrol S.A.’s total assets grew by 19.71%. In, 2023, the company’s net profit margin increased by 6.92%.

Headquarters
los Arupos E1-129, Galpon Bldg. , Floor 129
Quito; Pichincha;

Contact Details: Purchase the Nefrocontrol S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Nefrocontrol S.A. report to view the information.
Outstanding Shares:
Purchase the Nefrocontrol S.A. report to view the information.
Registered Capital:
Purchase the Nefrocontrol S.A. report to view the information.
Incorporation Date:
April 07, 1998
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Nefrocontrol S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
15.59%▲
Total operating revenue
16.44%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
1153.79%▲
Total assets
19.71%▲
Total equity
7.11%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
6.92%▲
Return on Equity (ROE)
5.89%▲
Debt to Equity Ratio
-1%▼
Quick Ratio
-0.18%▼
Cash Ratio
-0.06%▼

Similar companies

Laboratorios Siegfried S.A.
 
Roche Ecuador S.A.
Bayer S.A.
 
Novartis Ecuador S.A.
Laboratorios Industriales Farmaceuticos Ecuatorianos Life
 
Farmayala Pharmaceutical Company S.A.
Indeurec S.A.
 
Tecnandina S.A. Tensa
Laboratorio Vida S.A.
 
Merck Sharp & Dohme LLC
James Brown Pharma C.A.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo